KGK Synergize Receives Multi-Site ISO 9001:2000 Certification
KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO).
London, Ont. -- June 1, 2005 - KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO). The accredited registrar, SGS Systems & Services Certification Canada Inc., confirmed KGK's compliance through a formal audit process. The scope of registration is as follows: "The provision of laboratory testing, analytical services, pre-clinical trials and the establishment of protocols and methods for food products, nature, and the nutraceutical and pharmaceutical product industries in accordance with standard good laboratory practices".
"This important accreditation indicates the on-going dedication of our employees to continuously measure and improve the various processes at KGK, in an effort to present our clients with the best possible customer service available at a research organization", states Robert A. Guthrie, V.P., Contract Research Services Division. "KGK is dedicated to reacting to the needs of our consumers and ISO will enable us to monitor, track and record those needs accordingly".
KGK Synergize provides contract research services in the areas of nutraceutical research, analytical chemistry, immunology, toxicology, autoimmune diseases, etc. and clinical trials.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
